Chemotherapy 1995-01-01

In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone.

H Iwasaki, S Miyazaki, A Tsuji, K Yamaguchi, S Goto

Index: Chemotherapy 41(2) , 100-12, (1995)

Full Text: HTML

Abstract

Q-35, a new fluoroquinolone, was evaluated for its in vitro and in vivo antibacterial activities. In vitro antibacterial activity against gram-positive bacteria was almost equal to that of sparfloxacin or tosufloxacin, but its activity against gram-negative bacteria was 2 times or more lower than that of other quinolones tested. In experimental septicemia, the in vivo activity of Q-35 reflected its in vitro antibacterial activity. In respiratory tract infections with Streptococcus pneumoniae TMS-3 in mice, Q-35 showed a therapeutic effect similar to sparfloxacin and tosufloxacin. Q-35 showed almost the same activity as that of ofloxacin in mice with pyelonephritic infection due to Escherichia coli TMS-3. The peak levels of Q-35 in murine serum, lungs and kidneys after a single oral administration were intermediate compared to those of tested quinolones.

Related Compounds

  • Balofloxacin

Related Articles:

Determination of the new fluoroquinolone balofloxacin and its metabolites in biological fluids by high performance liquid chromatography.

1995-06-01

[Arzneimittelforschung 45(6) , 716-8, (1995)]

Photoallergenicity of a fluoroquinolone antibacterial agent with a fluorine substituent at the 8-position in guinea pigs exposed to long-wavelength UV light.

1998-01-01

[Skin Pharmacol. Appl. Skin Physiol. 11(4-5) , 232-40, (1998)]

Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.

2009-01-01

[Ophthalmic Res. 42(1) , 43-8, (2009)]

Alterations of protein complexes and pathways in genetic information flow and response to stimulus contribute to Escherichia coli resistance to balofloxacin.

2012-09-01

[Mol. Biosyst. 8(9) , 2303-11, (2012)]

High performance liquid chromatography-electrospray ionization mass spectrometric determination of balofloxacin in human plasma and its pharmacokinetics.

2007-05-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 850(1-2) , 68-73, (2007)]

More Articles...